Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
When discussing the role that nanotechnology might play in global health, the benefits that nano-enabled strategies could afford in terms of improving the outcomes of infectious diseases and curbing their spread include the possibility of producing integrated point-of-care devices for fast and simple diagnosis and monitoring; the development of efficient, possibly self-administered, drug releasing platforms that do not require multiple administration; the engineering of vaccines with controlled properties that could boost the immune response against pathogens that have so far escaped traditional immunisation strategies.
Image: Paramesh Karandikar and David Mankus of the Langer Lab and Nanotechnology Materials Core, respectively. Image created using elements sourced from NASA; CDC/Sarah Bailey Cutchin; CDC/Jessica A. Allen; CDC/Alissa Eckert (MSMI), Dan Higgins (MAMs)
In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research
Image: Image courtesy of Rita Acúrcio, University of Lisbon
Data-centric computation and the scalability limits of the traditional computing systems based on von Neumann architecture necessitate the development of alternative computational approaches for future nanoelectronics.